Hyamax® CaHA with Lidocaine (2 x 1.0 mL) | Laboratories Hyamed SA

Short Description

A dual-action hybrid biostimulator and structural dermal filler combining 20 mg/mL of cross-linked Hyaluronic Acid, smooth Calcium Hydroxylapatite (CaHA) microspheres (25–45 µm), and 0.3% lidocaine. Calibrated for deep dermal and subdermal placement, Hyamax® CaHA delivers immediate structural volumization while triggering sustained fibroblast-driven neocollagenesis and tissue remodeling—tightening the jawline, lifting the cheeks, and restoring tissue elasticity with clinical durability lasting 18 months up to 3 years.

Detailed Description

Hyamax® CaHA with Lidocaine is an advanced, sterile, biocompatible hybrid injectable developed by Laboratories Hyamed SA (Switzerland). Designed to bridge the gap between instant hydraulic volumizers and delayed regenerative biostimulators, the formulation features a synergistic two-phase matrix:

1. Cross-Linked Hyaluronic Acid Matrix (20 mg/mL): Acts as an immediate carrier and volumizing scaffold, providing initial mechanical projection, tissue hydration, and sharp contour definition upon extrusion.

2. Smooth Calcium Hydroxylapatite Microspheres (25–45 µm): Uniformly suspended within the HA gel carrier, these bio-ceramic microspheres function as a physical framework for native cellular ingrowth. Over time, as host macrophages and fibroblasts interact with the CaHA particles, a cascade of endogenous neocollagenesis (Type I and Type III collagen) and neo-elastogenesis is activated.

As the cross-linked HA carrier gradually metabolizes, newly synthesized native collagen bundles replace the carrier matrix around the slowly resorbing microspheres (which safely break down into physiological calcium and phosphate ions). This provides a natural, self-sustaining structural lift without unnatural bulk or rigid borders.

Treatment Areas & Indications

• Lower Face Sculpting & Jawline Tightening:

  • Mandibular angle sharpening and linear jawline definition

  • Pre-jowl sulcus effacement and lower face vector lifting

  • Chin augmentation, projection, and mental crease structural correction

• Midface Volumization & Lifting:

  • Malar and cheekbone projection (Zygomatic arch enhancement)

  • Submalar hollow correction and deep fat pad atrophy restoration

  • Moderate-to-severe nasolabial fold structural effacement

• Dermal Density & Tissue Laxity:

  • Flaccid skin along the lower lateral cheeks and pre-auricular zones

  • Moderate-to-severe marionette lines and oral commissure support

• Dorsal Hand Rejuvenation:

  • Subdermal volumization of the back of the hands, concealing prominent veins and bony tendons

Key Clinical Advantages

• Dual Immediate & Regenerative Action: Offers the instant gratification of cross-linked HA filler projection coupled with long-term, self-driven biological skin tightening and collagen regeneration.

• Calibrated Particle Geometry (25–45 µm): Smooth, spherical CaHA microspheres eliminate sharp particle edges, drastically reducing inflammatory foreign-body reactions and preventing nodule or granuloma formation.

• 100% Bioresorbable & Biocompatible: CaHA breaks down into natural calcium ($Ca^{2+}$) and phosphate ($PO_4^{3-}$) ions through physiological metabolic pathways, leaving behind only the patient’s newly synthesized collagen matrix.

• Anti-Migration Gel Carrier: Cross-linked HA prevents microsphere aggregation or displacement, ensuring the biostimulatory particles remain distributed at the target anatomical plane.

• Integrated 0.3% Lidocaine: Infused with lidocaine hydrochloride to desensitize deep tissues during needle or cannula extrusion, ensuring patient procedural comfort throughout high-resistance passes.

• Sustained Multi-Year Longevity: Delivers immediate volume that transitions into native tissue thickening, sustaining aesthetic results for 18 months to 3 years.

Technical Specifications

Professional Advisory: Hyamax® CaHA with Lidocaine is an advanced hybrid biostimulatory implant strictly indicated for certified dermatologists, plastic surgeons, and credentialed aesthetic physicians trained in sub-dermal vectoring and vascular risk management. It must never be injected into the glabella, forehead, lips, or periorbital/tear trough areas.